Civica, Inc. announces that Ned McCoy, currently Civica’s Chief Operating Officer, will succeed Martin VanTrieste as Civica’s President and Chief Executive Officer, effective June 1. VanTrieste will remain an advisor to the Company and continue serving on Civica’s Board of Directors. As part of this transition, McCoy will also join the Civica Board of...

I am writing in support of the H.R. 7559, the Prescription Information Modernization Act, which would allow provision of prescribing information in an electronic format, instead of on paper. Civica is a non-profit generic drug company established by U.S. health systems and three philanthropic organizations to reduce chronic drug shortages and ensure a safe...

Civica Rx today announced plans to manufacture and distribute insulins that, once approved, will be available to people with diabetes at significantly lower prices than insulins currently on the market. The availability of affordable insulins will benefit people with diabetes who have been forced to choose between life sustaining medicines and living expenses, particularly...

Congratulations, Martin VanTrieste for being named one of Modern Healthcare's "100 Most Influential in Healthcare."  Thank you for your tireless leadership, whether in the office, on Zoom, at a conference, or on the ground at our future Civica Petersburg manufacturing facility.  You inspire us to do what is in the best interest of patients...

Civica Rx  announced today that CivicaScript is the name for its operating unit dedicated to lowering the cost of select high-cost generic medicines, and that one of the nation’s largest health insurers and a leading drug manufacturer are joining the initiative. Anthem, Inc. – which operates affiliated health plans that provide health coverage to...

Modern Healthcare names Civica's Heather Wall, Chief Commercial officer, as a Top 25 Women Leader. Fast Company lists Civica as one of The World's 50 Most Innovative Companies for manufacturing generic drugs at lower prices to combat shortages and rising healthcare costs. Modern Healthcare names Martin VanTrieste, President and CEO of Civica Rx, as one...

The new facility, part of a partnership with Virginia-based Phlow Corp., will employ more than 180 people and will help ensure a safe, stable, and affordable supply of essential generic medicines for U.S. patients. Civica will produce sterile injectable medications used in hospitals for COVID-19 patient care, emergency room and intensive-care unit treatments, surgeries,...

We are so proud of Civica's Chief Commercial Officer, Heather Wall, for her recognition as one of Utah Business Magazine's "2020 CXO's of the Year." Heather has been instrumental in the design of Civica from concept to today.  “Heather is a force of nature - she inspires all of us with her energy, expertise...

Launched in 2018 as a nonprofit generic drug company to address the problem of chronic drug shortages, Civica Rx (Civica, Inc) has proven to be a viable industry player, ensuring stable and predictable supplies of over 20 essential generic drugs so far, and generating millions of dollars in savings for hospitals. The brainchild of...

Sandoz Inc. today announced it has entered into a long-term agreement with Civica Rx (Civica, Inc.) to manufacture and supply critical injectable generic medicines, to help reduce supply shortages and ensure acute care settings can deliver optimal patient care. Under the five-year agreement, Sandoz will supply six injectable medicines widely used at Civica’s 1,200...